Professur für Translationale Frauenheilkunde und Geburtshilfe

Inhibition of adhesion, proliferation, and invasion of primary endometriosis and endometrial stromal and ovarian carcinoma cells by a nonhyaluronan adhesion barrier gel (2015) Renner S, Strissel P, Beckmann M, Lermann J, Burghaus S, Hackl J, Fasching P, Strick R Journal article Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy (2015) Lindner JL, Loibl S, Denkert C, Ataseven B, Fasching P, Pfitzner BM, Gerber B, et al. Journal article A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density (2015) Rudolph A, Fasching P, Behrens S, Eilber U, Bolla MK, Wang Q, Thompson D, et al. Journal article Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures (2015) Stone J, Thompson DJ, Silva IDS, Scott C, Tamimi RM, Lindstrom S, Kraft P, et al. Journal article Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium (2015) Nagle CM, Dixon SC, Jensen A, Kjaer SK, Modugno F, Defazio A, Fereday S, et al. Journal article Population distribution of lifetime risk of ovarian cancer in the United States (2015) Pearce CL, Stram DO, Ness RB, Stram DA, Roman LD, Templeman C, Lee AW, et al. Journal article Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair (2015) Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, Stolk L, et al. Journal article Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2 (2015) Orr N, Dudbridge F, Dryden N, Maguire S, Novo D, Perrakis E, Johnson N, et al. Journal article Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study (2015) Hein A, Lambrechts D, Von Minckwitz G, Haeberle L, Eidtmann H, Tesch H, Untch M, et al. Journal article Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy (2015) Lei J, Rudolph A, Moysich KB, Rafiq S, Behrens S, Goode EL, Pharoah PP, et al. Journal article